DBTX Shares Outstanding History
Below is a table of the DBTX shares outstanding history going back to 2/12/2021:

Date DBTX Shares Outstanding
2/12/202123.12M
3/22/202124.90M
5/10/202124.90M
7/31/202124.90M
11/1/202124.92M
3/9/202224.96M
5/2/202224.96M
8/1/202224.96M

Also see: DBTX Market Cap History
DBTX YTD Return
DBTX Historical Shares Outstanding:
+5.37% CAGR
DBTX Historical Shares Outstanding: +5.37% CAGR

Mouse over chart for data details
2/12/2021 ...8/1/2022
Decibel Therapeutics is a clinical-stage biotechnology company focused on discovering and developing transformative treatments for hearing and balance disorders. Co. is developing its primary gene therapy product candidate, DB-OTO, to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin gene. In addition, Co. is advancing AAV.103 to restore hearing in individuals with mutations in the gap junction beta-2 gene and AAV.104 to restore hearing in individuals with mutations in the stereocilin gene. Co. is also developing DB-020 for the prevention of cisplatin-induced hearing loss, which it is evaluating in patients in a clinical trial. We show 8 historical shares outstanding datapoints in our coverage of DBTX's shares outstanding history.

Understanding the changing numbers of DBTX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DBTX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DBTX by allowing them to research DBTX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree DBTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Decibel Therapeutics (DBTX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

DCPH Shares Outstanding History
DCTH Shares Outstanding History
DEPO Shares Outstanding History
DERM Shares Outstanding History
DFFN Shares Outstanding History
DGX Shares Outstanding History
DHR Shares Outstanding History
DICE Shares Outstanding History
DMPI Shares Outstanding History
DMTK Shares Outstanding History
More Healthcare companies »

 

DBTX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.